wck-771 and Cross-Infection

wck-771 has been researched along with Cross-Infection* in 1 studies

Other Studies

1 other study(ies) available for wck-771 and Cross-Infection

Article	Year
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 WCK 771 demonstrated MIC(50) and MIC(90)s of 0.03 and 1 microg/ml, respectively, against 297 recent U.S. community-acquired and hospital strains of Staphylococcus aureus, irrespective of quinolone or glycopeptide resistance. Against quinolone-resistant strains, MIC(90)s of WCK 771 and moxifloxacin were 1 and 16 microg/ml, respectively. Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin Resistance	2009

Article

Year

In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.

Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

WCK 771 demonstrated MIC(50) and MIC(90)s of 0.03 and 1 microg/ml, respectively, against 297 recent U.S. community-acquired and hospital strains of Staphylococcus aureus, irrespective of quinolone or glycopeptide resistance. Against quinolone-resistant strains, MIC(90)s of WCK 771 and moxifloxacin were 1 and 16 microg/ml, respectively.

Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin Resistance

2009